Sawai Group Holdings Co., Ltd. (4887.T)
JPY 1905.0
(0.53%)
JPY 1905.0
(0.53%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 66.84 Billion JPY | 11.22% |
| 2022 | 60.09 Billion JPY | 12.05% |
| 2021 | 53.63 Billion JPY | -19.64% |
| 2020 | 66.74 Billion JPY | 10.19% |
| 2019 | 60.56 Billion JPY | -19.25% |
| 2018 | 75 Billion JPY | -5.99% |
| 2017 | 79.78 Billion JPY | 216.83% |
| 2016 | 25.18 Billion JPY | -13.15% |
| 2015 | 28.99 Billion JPY | 234.94% |
| 2014 | 8.65 Billion JPY | 34.91% |
| 2013 | 6.41 Billion JPY | -81.09% |
| 2012 | 33.92 Billion JPY | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 80.58 Billion JPY | 20.56% |
| 2023 FY | 66.84 Billion JPY | 11.22% |
| 2023 Q1 | 59.31 Billion JPY | -1.3% |
| 2023 Q2 | 58.45 Billion JPY | -1.45% |
| 2023 Q4 | 66.84 Billion JPY | 15.72% |
| 2023 Q3 | 57.76 Billion JPY | -1.19% |
| 2022 Q1 | 62.35 Billion JPY | 16.26% |
| 2022 FY | 60.09 Billion JPY | 12.05% |
| 2022 Q4 | 60.09 Billion JPY | -1.28% |
| 2022 Q3 | 60.87 Billion JPY | -1.26% |
| 2022 Q2 | 61.65 Billion JPY | -1.12% |
| 2021 Q2 | 55.19 Billion JPY | -1.39% |
| 2021 Q1 | 55.97 Billion JPY | -19.48% |
| 2021 FY | 53.63 Billion JPY | -19.64% |
| 2021 Q4 | 53.63 Billion JPY | -1.58% |
| 2021 Q3 | 54.49 Billion JPY | -1.26% |
| 2020 Q1 | 59.61 Billion JPY | -6.76% |
| 2020 FY | 66.74 Billion JPY | 10.19% |
| 2020 Q4 | 69.51 Billion JPY | 2.55% |
| 2020 Q2 | 58.65 Billion JPY | -1.6% |
| 2020 Q3 | 67.78 Billion JPY | 15.56% |
| 2019 Q3 | 61.6 Billion JPY | -15.21% |
| 2019 Q1 | 73.8 Billion JPY | -1.66% |
| 2019 Q2 | 72.65 Billion JPY | -1.56% |
| 2019 Q4 | 63.93 Billion JPY | 3.78% |
| 2019 FY | 60.56 Billion JPY | -19.25% |
| 2018 Q3 | 76.23 Billion JPY | -1.44% |
| 2018 FY | 75 Billion JPY | -5.99% |
| 2018 Q4 | 75.05 Billion JPY | -1.56% |
| 2018 Q2 | 77.35 Billion JPY | -1.57% |
| 2018 Q1 | 78.58 Billion JPY | -2.18% |
| 2017 Q4 | 80.33 Billion JPY | -1.46% |
| 2017 FY | 79.78 Billion JPY | 216.83% |
| 2017 Q1 | 25.57 Billion JPY | -1.89% |
| 2017 Q2 | 25.13 Billion JPY | -1.73% |
| 2017 Q3 | 81.52 Billion JPY | 224.35% |
| 2016 Q3 | 26.47 Billion JPY | -1.83% |
| 2016 Q2 | 26.96 Billion JPY | -1.61% |
| 2016 FY | 25.18 Billion JPY | -13.15% |
| 2016 Q4 | 26.07 Billion JPY | -1.53% |
| 2016 Q1 | 27.4 Billion JPY | -1.76% |
| 2015 Q2 | 18.82 Billion JPY | -2.56% |
| 2015 FY | 28.99 Billion JPY | 234.94% |
| 2015 Q4 | 27.9 Billion JPY | -1.56% |
| 2015 Q3 | 28.34 Billion JPY | 50.58% |
| 2015 Q1 | 19.31 Billion JPY | 123.13% |
| 2014 Q1 | 5.85 Billion JPY | -8.8% |
| 2014 Q2 | 5.33 Billion JPY | -8.77% |
| 2014 Q3 | 4.87 Billion JPY | -8.71% |
| 2014 Q4 | 8.65 Billion JPY | 77.62% |
| 2014 FY | 8.65 Billion JPY | 34.91% |
| 2013 FY | 6.41 Billion JPY | -81.09% |
| 2013 Q4 | 6.41 Billion JPY | 176.59% |
| 2013 Q3 | 2.32 Billion JPY | -88.5% |
| 2013 Q2 | 20.17 Billion JPY | -39.75% |
| 2013 Q1 | 33.47 Billion JPY | -1.32% |
| 2012 Q3 | 34.54 Billion JPY | -1.82% |
| 2012 Q4 | 33.92 Billion JPY | -1.78% |
| 2012 Q2 | 35.18 Billion JPY | 0.0% |
| 2012 FY | 33.92 Billion JPY | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 1.23 Billion JPY | -5329.813% |
| Takeda Pharmaceutical Company Limited | 4476.5 Billion JPY | 98.507% |
| Sumitomo Pharma Co., Ltd. | 133.36 Billion JPY | 49.882% |
| Shionogi & Co., Ltd. | 8.75 Billion JPY | -663.635% |
| Wakamoto Pharmaceutical Co.,Ltd. | - JPY | -Infinity% |
| Nippon Shinyaku Co., Ltd. | 1.15 Billion JPY | -5702.17% |
| Kaken Pharmaceutical Co., Ltd. | - JPY | -Infinity% |
| Eisai Co., Ltd. | 134.77 Billion JPY | 50.405% |
| Morishita Jintan Co., Ltd. | 106 Million JPY | -62957.547% |
| Hisamitsu Pharmaceutical Co., Inc. | 76 Million JPY | -87848.684% |
| Mochida Pharmaceutical Co., Ltd. | - JPY | -Infinity% |
| Fuso Pharmaceutical Industries,Ltd. | 7.02 Billion JPY | -852.015% |
| Nippon Chemiphar Co., Ltd. | 13.34 Billion JPY | -400.907% |
| Tsumura & Co. | 54.37 Billion JPY | -22.921% |
| Kissei Pharmaceutical Co., Ltd. | - JPY | -Infinity% |
| Torii Pharmaceutical Co., Ltd. | 22 Million JPY | -303722.727% |
| Towa Pharmaceutical Co., Ltd. | 189.12 Billion JPY | 64.658% |
| Fuji Pharma Co., Ltd. | 11.92 Billion JPY | -460.559% |
| Zeria Pharmaceutical Co., Ltd. | 7.94 Billion JPY | -741.424% |
| KYORIN Holdings, Inc. | 435 Million JPY | -15265.747% |
| Taiko Pharmaceutical Co.,Ltd. | 2.74 Billion JPY | -2338.563% |
| Daito Pharmaceutical Co.,Ltd. | 4.66 Billion JPY | -1331.591% |
| SymBio Pharmaceuticals Limited | - JPY | -Infinity% |
| MedRx Co., Ltd | - JPY | -Infinity% |
| Mizuho Medy Co.,Ltd. | - JPY | -Infinity% |
| Solasia Pharma K.K. | 27 Million JPY | -247459.259% |
| Modalis Therapeutics Corporation | 412.5 Million JPY | -16103.879% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | 4.5 Billion JPY | -1383.707% |
| Cyfuse Biomedical K.K. | 345 Million JPY | -19274.203% |
| Toho Holdings Co., Ltd. | 28.16 Billion JPY | -137.311% |
| Koa Shoji Holdings Co.,Ltd. | 1.59 Billion JPY | -4100.18% |